Press releases

Indiana CTSI partners with GVK Biosciences to provide national access to biomarkers database

June 08, 2011, Hyderabad: In an agreement facilitated by the Indiana Economic Development Corporation (IEDC) during a February economic mission to India, the Indiana Clinical and Translational Sciences Institute (CTSI) has partnered with GVK Biosciences, Asia's leading Contract Research Organization, to provide researchers across the United States access to GVK BIO's Clinical Biomarker Database that will advance research on wide range of diseases. The Indiana CTSI Bioinformatics Core and Indiana Institute for Personalized Medicine will work together to manage the process by which researchers access this new resource. The GVK Biosciences Clinical Biomarker Database known as (GOBIOM) is a comprehensive collection of all clinically evaluated, exploratory and preclinical biomarkers associated with different therapeutic areas reported in global clinical trials, clinical and preclinical studies. The resource will be available nationwide to 55 medical centers and universities supported by the Clinical and Translational Sciences Award from the National Institutes of Health. "The GOBIOM database is a powerful tool for clinicians and researchers looking to mine the most up to date and comprehensive information about any putative biomarker for personalized therapeutics," said Anantha Shekhar, director of the Indiana CTSI. "The Indiana CTSI is very pleased to partner with GVK BIO and the Indiana Institute for Personalized Medicine to make this resource available to all clinical and translational researchers in the national consortium. I am also grateful to the Indiana Economic Development Corporation for facilitating the GVK BIO and CTSI partnership." "GVK BIO is pleased that the Indiana CTSI chose the GVK BIO Biomarker Database for its research efforts. Biomarker research is increasing at a rapid pace and the database is designed to help researchers keep pace with the latest data. We look forward to collaborating with the CTSI and further improving the product to address the needs of the researchers and reviewers," said Sreeni Devidas, Ph.D., vice president for sales and marketing in informatics at GVK Biosciences. "From research and development to commercialization, Indiana's wealth of expertise in life sciences has improved the knowledge and quality of medicine for researchers and patients around the world. The partnership between GVK Biosciences and the Indiana CTSI sprung from initial meetings during our February economic mission to India and has quickly developed into a tangible partnership that could be the precursor for future global opportunities," said Mitch Roob, secretary of commerce and chief executive officer of IEDC. GOBIOM contains information on 12,000 biomarkers comprising biochemical, genomic, imaging, metabolite, cellular and physiological markers with multiple data points covering experimental, analytical, clinical and statistical data with their qualifications under different medical interventions. The GOBIOM database contains the latest and updated information on all the biomarkers reported in various clinical and preclinical studies.

Salient features of GOBIOM

  1. Controlled vocabulary throughout
  2. Web-enabled search application for quick and easy access
  3. Intuitive User Interface with comprehensive search features
  4. Instant generation of ‘biomarker report’
  5. Data export options in custom format to Excel, XML and PDF
  6. Provision of user-required data in their own formats
  7. Easy integration with client proprietary data
  8. On-demand service for any biomarker addition into the database
  9. Competitive intelligence analysis
  10. "Alert a Colleague" option to share the data with other users
  11. Biweekly update with auto alert function
  12. Custom alert by therapeutic area and biomarker name
  13. On-demand training sessions
  14. A dedicated server located in USA with backup server in India

Latest news on biomarker